chr11-55638701-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001004124.2(OR4P4):c.344G>A(p.Gly115Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000114 in 1,491,310 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001004124.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR4P4 | NM_001004124.2 | c.344G>A | p.Gly115Glu | missense_variant | 1/1 | NP_001004124.1 | ||
OR4P4 | NM_001405919.1 | c.344G>A | p.Gly115Glu | missense_variant | 2/2 | NP_001392848.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR4P4 | ENST00000641760.1 | c.344G>A | p.Gly115Glu | missense_variant | 2/2 | ENSP00000493384.1 |
Frequencies
GnomAD3 genomes AF: 0.0000795 AC: 11AN: 138418Hom.: 3 Cov.: 25
GnomAD4 exome AF: 0.00000443 AC: 6AN: 1352892Hom.: 1 Cov.: 30 AF XY: 0.00000446 AC XY: 3AN XY: 673058
GnomAD4 genome AF: 0.0000795 AC: 11AN: 138418Hom.: 3 Cov.: 25 AF XY: 0.0000595 AC XY: 4AN XY: 67196
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 06, 2023 | The c.344G>A (p.G115E) alteration is located in exon 1 (coding exon 1) of the OR4P4 gene. This alteration results from a G to A substitution at nucleotide position 344, causing the glycine (G) at amino acid position 115 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at